Form D · Private Equity Fund
PCA Opportunities Fund 2022, L.P. - Series A (Life Sciences III)
Greenwich, CT · CIK 0001874792
Offering snapshot reported Jul 29, 2022 · SEC filing
- Reported sold
- $43.1M Indefinite offering
- Investors reported
- 81 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Oct 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 29, 2022 | Amendment | $43,100,000 | No comparison | 81 | SEC filing |
| Jul 30, 2021 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-408370
Source: Form D, filed Jul 29, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Todd Kesselman | Executive |
| Gina La Versa | Executive |
| Precision Capital 2022 Gp, L.P. | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Precision Capital 2022 Gp, L.P. 171 Greenwich Avenue, Third Floor
Greenwich, CT, 06830
Greenwich, CT, 06830